Approvals/TGA/SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle

Approved

STANDARD

SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cf0bad418acc47dd
Product Name: SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle
Artg Id: 401897
Artg Name: SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2023-08-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

cf0bad418acc47dd

Type

Standard